Cancer: calculated treatment (Q42881522)

9 November 2017

Cancer: calculated treatment (English)

1 reference

9 November 2017

Natalia L Komarova

1

1 reference

9 November 2017

C Richard Boland

series ordinal

2

1 reference

9 November 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

9 November 2017

1 reference

9 November 2017

499

1 reference

9 November 2017

7458

1 reference

9 November 2017

291-292

1 reference

https://scigraph.springernature.com/pub.10.1038/499291a

9 November 2017

0 references

cites work

Evolutionary dynamics of cancer in response to targeted combination therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831845

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831845

Optimizing combination therapies with existing and future CML drugs

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831845

Combination of two but not three current targeted drugs can improve therapy of chronic myeloid leukemia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831845

Targeting cancer with small molecule kinase inhibitors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831845

Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831845

Drug resistance in cancer: principles of emergence and prevention

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831845

The worst drug rule revisited: mathematical modeling of cyclic cancer treatments

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3831845

16 August 2018

Identifiers

DOI

10.1038/499291A

1 reference

Dimensions Publication ID

9 November 2017

0 references

1 reference

9 November 2017

1 reference